• Aimei Health posted net income of USD 1.06 million for year ended Dec. 31, 2025, down from USD 2.55 million a year earlier.
• Interest earned on cash held in Trust Account fell to USD 1.9 million from USD 3.62 million, while general, administrative and operational costs decreased to USD 835,759 from USD 1.06 million.
• Trust Account balance stood at USD 12.1 million at year-end, while operating bank account cash was USD 2,929 and working capital deficit was about USD 3.37 million.
• Blank-check company reiterated it expects to close proposed United Hydrogen business combination by May 2026, pending required CSRC approvals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aimei Health Technology Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-021108), on May 04, 2026, and is solely responsible for the information contained therein.